Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company LFB S.A.
DescriptionRecombinant human alpha-1 antitrypsin (AAT; A1AT; SERPINA1)
Molecular Target Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationEmphysema
Indication DetailsTreat hereditary emphysema
Regulatory Designation
PartnerrEVO Biologics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today